לבטיראצטם טבע ® 250 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

לבטיראצטם טבע ® 250 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 250 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם טבע ® 500 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

לבטיראצטם טבע ® 500 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 500 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם טבע ® 1000 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

לבטיראצטם טבע ® 1000 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 1000 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבופר פלוס 125 Ισραήλ - Εβραϊκά - Ministry of Health

לבופר פלוס 125

teva pharmaceutical indust.ltd - benserazide as hydrochloride 25 mg; levodopa 100 mg - capsules - levodopa - for the relief of symptoms associated with parkinson's disease.

לבופר פלוס 250 Ισραήλ - Εβραϊκά - Ministry of Health

לבופר פלוס 250

teva pharmaceutical indust.ltd - benserazide as hydrochloride 50 mg; levodopa 200 mg - capsules - levodopa and decarboxylase inhibitor - for the relief of symptoms associated with parkinson's disease.

לבופר פלוס 250 Ισραήλ - Εβραϊκά - Ministry of Health

לבופר פלוס 250

teva pharmaceutical indust.ltd - benserazide as hydrochloride 50 mg; levodopa 200 mg - capsules - levodopa and decarboxylase inhibitor - for the relief of symptoms associated with parkinson's disease.

פרגוליד טבע ® 0.25 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

פרגוליד טבע ® 0.25 מ"ג

teva pharmaceutical indust.ltd - pergolide as mesylate 0.25 mg - tablets - pergolide - pergolide is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of parkinson's disease with on-off phenomena. pergolide is indicated as monotherapy in the initial treatment period of parkinson's disease.

אוטרקס 25 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

אוטרקס 25 מ"ג

teva pharmaceutical indust.ltd - hydroxyzine hydrochloride 25 mg - tablets - hydroxyzine - anxiety and tension. pruritus. behavior disturbances in children. preoperative sedation.

אוטרקס 25 מ"ג Ισραήλ - Εβραϊκά - Ministry of Health

אוטרקס 25 מ"ג

teva pharmaceutical indust.ltd - hydroxyzine hydrochloride 25 mg - tablets - hydroxyzine - anxiety and tension. pruritus. behavior disturbances in children. preoperative sedation.

נומבון Ισραήλ - Εβραϊκά - Ministry of Health

נומבון

teva pharmaceutical indust.ltd - nitrazepam 5 mg - tablets - nitrazepam - insomnia of various etiology.